Eli Lilly and Company (LLY)
NYSE · Health Care · market cap 985.37B
Share price
$1152.44
At the last nightly close
Intrinsic value
$364.45
A single conservative estimate.
Margin of safety
-68.4%
($364.45 − $1152.44) ÷ $1152.44
EV / EBIT
n/a
Not ranked: short history.
How these numbers are computed
The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above is the low end of what they agree on.
The frame gives no credit for growth. A company that compounds will therefore read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.
The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.
Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-08-25.
Key metrics
Market position
Annual financials
| Period | Revenue | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|
| 2025-FY | 65.18B | 29.70B | 20.64B | 23.07 | 5.96B |
| 2024-FY | 45.04B | 17.04B | 10.59B | 11.80 | 414.0M |
| 2023-FY | 34.12B | 10.32B | 5.24B | 5.83 | -3.15B |
| 2022-FY | 28.54B | 8.28B | 6.24B | 6.57 | 4.60B |
| 2021-FY | 28.32B | n/a | 5.58B | 6.12 | n/a |
Filed figures from SEC EDGAR, in the reporting currency.
Next earnings
Recent news
- Eli Lilly Stock (LLY) Opinions on Upcoming Earnings Release | Quiver Quantitativequiverquant.com
- 5 Catalysts to Monitor Over In The Next 2 Quarters For LLY Stock | Trefistrefis.com
- Eli Lilly Is Up 7% in 2026 and Has Major Catalysts on the ...fool.com
- Eli Lilly (NYSE:LLY) - Stock Analysis - Simply Wall Stsimplywall.st
- 3 Price Catalysts For Eli Lilly (NYSE:LLY) | Seeking Alphaseekingalpha.com
Headlines link to their source. Sperio does not republish article text.
The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on LLY.
Run the board on LLY10 free analyses · no signup, no card
This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.